KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Return on Equity data on record, last reported at 0.16% in Q3 2025.

  • For Q3 2025, Return on Equity fell 15.0% year-over-year to 0.16%; the TTM value through Sep 2025 reached 0.16%, down 15.0%, while the annual FY2024 figure was 0.12%, 60.0% up from the prior year.
  • Return on Equity reached 0.16% in Q3 2025 per SRPT's latest filing, down from 0.2% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.31% in Q3 2024 and bottomed at 1.24% in Q2 2021.
  • Average Return on Equity over 5 years is 0.42%, with a median of 0.4% recorded in 2022.
  • Peak YoY movement for Return on Equity: plummeted -83bps in 2023, then skyrocketed 151bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.6% in 2021, then dropped by -8bps to 0.65% in 2022, then surged by 44bps to 0.37% in 2023, then surged by 128bps to 0.1% in 2024, then soared by 58bps to 0.16% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.16% in Q3 2025, 0.2% in Q2 2025, and 0.08% in Q1 2025.